BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 17581233)

  • 1. From bacterial genomes to novel antibacterial agents: discovery, characterization, and antibacterial activity of compounds that bind to HI0065 (YjeE) from Haemophilus influenzae.
    Lerner CG; Hajduk PJ; Wagner R; Wagenaar FL; Woodall C; Gu YG; Searle XB; Florjancic AS; Zhang T; Clark RF; Cooper CS; Mack JC; Yu L; Cai M; Betz SF; Chovan LE; McCall JO; Black-Schaefer CL; Kakavas SJ; Schurdak ME; Comess KM; Walter KA; Edalji R; Dorwin SA; Smith RA; Hebert EJ; Harlan JE; Metzger RE; Merta PJ; Baranowski JL; Coen ML; Thornewell SJ; Shivakumar AG; Saiki AY; Soni N; Bui M; Balli DJ; Sanders WJ; Nilius AM; Holzman TF; Fesik SW; Beutel BA
    Chem Biol Drug Des; 2007 Jun; 69(6):395-404. PubMed ID: 17581233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the YjeE protein from Haemophilus influenzae: a putative Atpase involved in cell wall synthesis.
    Teplyakov A; Obmolova G; Tordova M; Thanki N; Bonander N; Eisenstein E; Howard AJ; Gilliland GL
    Proteins; 2002 Aug; 48(2):220-6. PubMed ID: 12112691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel targets for the future development of antibacterial agents.
    McDevitt D; Payne DJ; Holmes DJ; Rosenberg M
    Symp Ser Soc Appl Microbiol; 2002; (31):28S-34S. PubMed ID: 12481826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic approaches to antibacterial discovery.
    Payne DJ; Gwynn MN; Holmes DJ; Rosenberg M
    Methods Mol Biol; 2004; 266():231-59. PubMed ID: 15148422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships.
    Charifson PS; Grillot AL; Grossman TH; Parsons JD; Badia M; Bellon S; Deininger DD; Drumm JE; Gross CH; LeTiran A; Liao Y; Mani N; Nicolau DP; Perola E; Ronkin S; Shannon D; Swenson LL; Tang Q; Tessier PR; Tian SK; Trudeau M; Wang T; Wei Y; Zhang H; Stamos D
    J Med Chem; 2008 Sep; 51(17):5243-63. PubMed ID: 18690678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When will the genomics investment pay off for antibacterial discovery?
    Mills SD
    Biochem Pharmacol; 2006 Mar; 71(7):1096-102. PubMed ID: 16387281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation, structure and antibacterial activity of pleosporone from a pleosporalean ascomycete discovered by using antisense strategy.
    Zhang C; Ondeyka JG; Zink DL; Basilio A; Vicente F; Collado J; Platas G; Huber J; Dorso K; Motyl M; Byrne K; Singh SB
    Bioorg Med Chem; 2009 Mar; 17(6):2162-6. PubMed ID: 18442914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic analyses lead to novel secondary metabolites. Part 3. ECO-0501, a novel antibacterial of a new class.
    Banskota AH; Mcalpine JB; Sørensen D; Ibrahim A; Aouidate M; Piraee M; Alarco AM; Farnet CM; Zazopoulos E
    J Antibiot (Tokyo); 2006 Sep; 59(9):533-42. PubMed ID: 17136886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A strategy for high-throughput assay development using leads derived from nuclear magnetic resonance-based screening.
    Hajduk PJ; Betz SF; Mack J; Ruan X; Towne DL; Lerner CG; Beutel BA; Fesik SW
    J Biomol Screen; 2002 Oct; 7(5):429-32. PubMed ID: 14599358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biaryl isoxazolinone antibacterial agents.
    Quesnelle CA; Gill P; Roy S; Dodier M; Marinier A; Martel A; Snyder LB; D'Andrea SV; Bronson JJ; Frosco M; Beaulieu D; Warr GA; Denbleyker KL; Stickle TM; Yang H; Chaniewski SE; Ferraro CA; Taylor D; Russell JW; Santone KS; Clarke J; Drain RL; Knipe JO; Mosure K; Barrett JF
    Bioorg Med Chem Lett; 2005 Jun; 15(11):2728-33. PubMed ID: 15869878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation, structure, and antibacterial activity of philipimycin, a thiazolyl peptide discovered from Actinoplanes philippinensis MA7347.
    Zhang C; Occi J; Masurekar P; Barrett JF; Zink DL; Smith S; Onishi R; Ha S; Salazar O; Genilloud O; Basilio A; Vicente F; Gill C; Hickey EJ; Dorso K; Motyl M; Singh SB
    J Am Chem Soc; 2008 Sep; 130(36):12102-10. PubMed ID: 18698773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.
    Foloppe N; Chen IJ; Davis B; Hold A; Morley D; Howes R
    Bioorg Med Chem; 2004 Mar; 12(5):935-47. PubMed ID: 14980606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial genomics and drug discovery: exploring innovative routes of drug discovery in the postgenomic era.
    Dougherty TJ; Miller PF
    IDrugs; 2006 Jun; 9(6):420-2. PubMed ID: 16752312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of genomics to select antibacterial targets.
    Pucci MJ
    Biochem Pharmacol; 2006 Mar; 71(7):1066-72. PubMed ID: 16412986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystallizing new approaches for antimicrobial drug discovery.
    Schmid MB
    Biochem Pharmacol; 2006 Mar; 71(7):1048-56. PubMed ID: 16458857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel anti-infection agents: small-molecule inhibitors of bacterial transcription factors.
    Bowser TE; Bartlett VJ; Grier MC; Verma AK; Warchol T; Levy SB; Alekshun MN
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5652-5. PubMed ID: 17766109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel targets for the future development of antibacterial agents.
    McDevitt D; Payne DJ; Holmes DJ; Rosenberg M
    J Appl Microbiol; 2002; 92 Suppl():28S-34S. PubMed ID: 12000610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional genomics in antibacterial drug discovery.
    Freiberg C; Brötz-Oesterhelt H
    Drug Discov Today; 2005 Jul; 10(13):927-35. PubMed ID: 15993812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and antibacterial activities of novel 3,6-bicyclolide oximes: length optimization and zero carbon linker oximes.
    Tang D; Gai Y; Polemeropoulos A; Chen Z; Wang Z; Or YS
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5078-82. PubMed ID: 18762418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel genomic approach identifies bacterial DNA-dependent RNA polymerase as the target of an antibacterial oligodeoxynucleotide, RBL1.
    Tan XX; Chen Y
    Biochemistry; 2005 May; 44(17):6708-14. PubMed ID: 15850405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.